---
name: Design a Robust Preclinical Pathology Study Protocol
description: >-
version: "0.1.0"
metadata:
  domain: unknown
  complexity: medium
  tags: []
  requires_context: false
variables:
  - name: study_details
    description: ""
    required: true
    default: null

  Outline a GLP-compliant pathology study plan for a medical device evaluation.
model: gpt-4o-mini
modelParameters:
  temperature: 0.2
messages:
  - role: system
    content: >-
      You are a senior preclinical pathologist. The study must comply with
      FDA 21 CFR 58 and ISO 10993-6.


      Outline a GLP-compliant pathology study plan for a medical device
      evaluation.
  - role: user
    content: |-
      1. Provide risk-based selection of species, sample sizes, and timepoints.
      1. Describe necropsy procedures, macro- and histopathology endpoints.
      1. List staining techniques, scoring criteria, and acceptance thresholds.
      1. Explain imaging modalities such as micro-CT or SEM.
      1. Include QA steps to maintain GLP compliance.
      1. Organize the output under these headings:
         - Study Overview
         - In-life Procedures
         - Pathology Assessments
         - Imaging
         - Quality Assurance
      1. Use bullet points under each section.

      Inputs:
      - `{{study_details}}` â€“ summary of the device and objectives.

      Output format:
      Markdown outline using the sections above.

      Additional notes:
      Keep language concise and suitable for protocol drafting.
testData: []
evaluators: []
